Avaliação endometrial em pacientes usuárias de tamoxifeno

Barra, Alexandre de Almeida; Santos, Annamaria Massahud Rodrigues dos; Barros, Cristovão Pinheiro de; Silveira, Daniel Sad; Balabram, Débora; Soares, Karina Ferreira; Trota, Silmara Teixeira Alves.
Femina ; 41(1): 5-8, jan-fev. tab
Artículo en Portugués | LILACS | ID: lil-694472

Documentos relacionados

  1. Meta-analysis of the cumulative risk of endometrial malignancy and systematic review of endometrial surveillance in extended tamoxifen therapy.
  2. Asymptomatic postmenopausal women: what are the risk factors for endometrial malignancies? A multicentric retrospective study.
  3. SWATH-MS Analysis of FFPE Tissues Identifies Stathmin as a Potential Marker of Endometrial Cancer in Patients Exposed to Tamoxifen.
  4. Tamoxifen Regulates Epithelial-Mesenchymal Transition in Endometrial Cancer via the CANP10/NRP1 Signaling Pathway.
  5. A new perspective on Endometrial Carcinoma classification and management strategies in context of molecular subtypes.
  6. The relationship of endometrial pathologies with endometrial thickness and inflammatory markers in breast cancers using tamoxifen.
  7. Palliative treatment of endometrial cancer: what is the role of anastrozole in elderly women?
  8. Assessment of Tamoxifen-Related Endometrial Changes in Premenopausal Female Patients With Diffusion-Weighted Magnetic Resonance Imaging.
  9. Hysteroscopic Endometrial Resection in Women Treated With Tamoxifen for Breast Cancer Provides Definitive Diagnosis and Effective Long-Term Therapy.
  10. [Endometrial cancer in the crossroads of modernity and immunotherapy].